XML 19 R10.htm IDEA: XBRL DOCUMENT

Operating Segments

9 Months Ended

Sep. 30, 2021

Note 4: Operating Segments

General:

The company has two operating segments, as follows:

Proprietary Products	-	Development, manufacturing, sales, and distribution of plasma-derived protein therapeutics.

Distribution	-	Distribute imported drug products in Israel, which are manufactured by third parties.

Reporting on operating segments:

	Nine months period ended September 30, 2021
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited

Revenues	$	57,316	$	14,857	$	72,173
Gross profit	$	21,711	$	2,022	$	23,733
Unallocated corporate expenses						(21,127	)
Finance income, net						173
Income before taxes on income					$	2,779

	Nine months period ended September 30, 2020
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited

Revenues	$	77,633	$	24,071	$	101,704
Gross profit	$	33,816	$	3,571	$	37,387
Unallocated corporate expenses						(20,799	)
Finance income, net						67
Income before taxes on income					$	16,655

	Three months period ended September 30, 2021
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited

Revenues	$	17,123	$	5,911	$	23,034
Gross profit	$	5,045	$	685	$	5,730
Unallocated corporate expenses						(6,534	)
Finance expenses, net						(41	)
Income before taxes on income					$	(845	)

	Three months period ended September 30, 2020
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited

Revenues	$	29,691	$	5,634	$	35,325
Gross profit	$	13,755	$	1,066	$	14,821
Unallocated corporate expenses						(7,058	)
Finance expenses, net						(580	)
Income before taxes on income					$	7,183

	Year Ended December 31, 2020
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Audited

Revenues	$	100,916	$	32,330	$	133,246
Gross profit	$	43,166	$	4,386	$	47,552
Unallocated corporate expenses						(28,315	)
Finance expenses, net						(672	)
Income before taxes on income					$	18,565

Reporting on operating segments by geographic region:

	Nine months period ended September 30, 2021
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited
Geographical markets
U.S.A and North America	$	39,265		-	$	39,265
Israel		6,437		14,857		21,294
Europe		4,491		-		4,491
Latin America		5,255		-		5,255
Asia		1,753		-		1,753
Others		115		-		115
	$	57,316	$	14,857	$	72,173

	Nine months period ended September 30, 2020
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited
Geographical markets
U.S.A and North America	$	66,339	$	-	$	66,339
Israel		3,132		24,071		27,203
Europe		3,690		-		3,690
Latin America		3,976		-		3,976
Asia		444		-		444
Others		52		-		52
	$	77,633	$	24,071	$	101,704

	Three months period ended September 30, 2021
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited
Geographical markets
U.S.A and North America.	$	12,710			$	12,710
Israel		849		5,911		6,760
Europe		1,097				1,097
Latin America		1,652				1,652
Asia		734				734
Others		81				82
	$	17,123	$	5,911	$	23,034

	Three months period ended September 30, 2020
	Proprietary Products		Distribution		Total
	U.S Dollars in thousands
	Unaudited
Geographical markets
U.S.A and North America	$	25,879	$	-	$	25,879
Israel		1,126		5,634		6,760
Europe		403		-		403
Latin America		2,104		-		2,104
Asia		158		-		158
Others		21		-		21
	$	29,691	$	5,634	$	35,325